Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

ClinicalTrials.gov ID: NCT01880424

Public ClinicalTrials.gov record NCT01880424. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01880424
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,722 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Linaclotide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2013
Primary completion
Apr 30, 2015
Completion
Apr 30, 2015
Last update posted
Sep 26, 2016

2013 – 2015

United States locations

U.S. sites
52
U.S. states
21
U.S. cities
52
Facility City State ZIP Site status
Research Site Huntsville Alabama
Research Site North Little Rock Arkansas
Research Site Phoenix Arkansas
Research Site Artesia California
Research Site Chula Vista California
Research Site Encino California
Research Site North Hollywood California
Research Site Orange California
Research Site Riverside California
Research Site San Diego California
Research Site Boynton Beach Florida
Research Site Brandon Florida
Research Site Brooksville Florida
Research Site Doral Florida
Research Site Gainesville Florida
Research Site Hialeah Florida
Research Site Kissimmee Florida
Research Site Lauderdale Lakes Florida
Research Site Miami Florida
Research Site Miami Lakes Florida
Research Site Addison Illinois
Research Site Evansville Indiana
Research Site Crowley Louisiana
Research Site Monroe Louisiana
Research Site Shreveport Louisiana
Research Site Boston Massachusetts
Research Site Chesterfield Michigan
Research Site Wyoming Michigan
Research Site St Louis Missouri
Research Site Billings Montana
Research Site Las Vegas Nevada
Research Site Brooklyn New York
Research Site Great Neck New York
Research Site New York New York
Research Site Raleigh North Carolina
Research Site Salisbury North Carolina
Research Site Winston-Salem North Carolina
Research Site Cincinnati Ohio
Research Site Dayton Ohio
Research Site Franklin Ohio
Research Site Mentor Ohio
Research Site Greer South Carolina
Research Site Chattanooga Tennessee
Research Site Kingsport Tennessee
Research Site Knoxville Tennessee
Research Site Smyrna Tennessee
Research Site Houston Texas
Research Site San Antonio Texas
Research Site Webster Texas
Research Site Ogden Utah
Research Site Lynchburg Virginia
Research Site Morgantown West Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01880424, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 26, 2016 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01880424 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →